Vehicle-Based Drug Photosensitivity Testing Discouraged By CTFA
This article was originally published in The Tan Sheet
Photosensitivity testing of reformulated topical drugs is unnecessary and should not be encouraged by FDA, the Cosmetic, Toiletry & Fragrance Association advises in recent comments on the agency's draft guidance on photosafety testing.
You may also be interested in...
Warnings that convey the risks of certain photosensitizing products may be sufficient without requiring long-term photosafety testing, FDA suggests in a recently released draft guidance on "Photosafety Testing."
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning